03/08/2023 - PHARMANUTRA S.P.A.: CETILAR® WITH MARCELL JACOBS HEADING FOR PARIS 2024

PHARMANUTRA S.P.A.: CETILAR® WITH MARCELL JACOBS

HEADING FOR PARIS 2024

The Italian pharmaceutical brand, which already supports other world-class sports ventures, will join the world athletic star, two-time Olympic champion in Tokyo, on his journey towards the World Athletics Championships in Budapest in August and the Paris Olympic Games in 2024.

Pisa, 3 August 2023 - Another champion joins the great Cetilar® family: after officially launching the partnership with the Spanish driver Fernando Alonso at the end of May, PharmaNutra S.p.A.(MTA; Ticker PHN), a company specialised in mineral nutritional supplements and medical devices for muscles and joints, just announced that it has reached a collaboration agreement with world athletic star Marcell Jacobs, double Olympic gold medal champion at the 2020 Tokyo Games in the 100 metres and the 4x100 men's relay. Jacobs is 28 years old, born in El Paso (Texas, USA), his mother is Italian and his father is American, but he has lived in Italy since he was very young. He is a member of the Fiamme Ore Team (the sports section of the Italian Police) and the star of the Italian National Athletics Team, an extraordinary champion who after the historic double Olympic gold medal wins in Tokyo, went on to win the World Indoor title in the 60 metres sprint in Belgrade 2022 and the European title in the 100 metres sprint in Munich, also in 2022. This year he won a silver medal at the European Indoor Championships in Istanbul in the 60 metres sprint, before stopping to recover from a physical discomfort that forced him to give up other competitions to focus on the most important event of the year, the World Athletic Championships in Budapest (Hungary) from 19 to 27 August. To arrive at the Worlds in the best possible fitness, Jacobs is following an intense training program at the Paolo Rosi Stadium, in Rome.

A journey during which Jacobs will be supported by the Cetilar® brand, a line of products dedicated to the treatment of muscles and joints based on Cetylated Fatty Acids (CFAs), and available in various versions: Cream, Patch, Tape and Gold, but that's not all. In fact, since last March, Cetilar®, an exclusive PharmaNutra brand, also launched Nutrition, a new line of products dedicated to nutrition and improving the performance of competitive athletes. It's the result of years of studies in the nutritional field that the company founded in 2003 by brothers Andrea and Roberto Lacorte has carried on thanks to its technologies and its patents.

Furthermore, in 2020 Cetilar® brand products obtained Play Sure Doping Free certification, issued by the non-profit association No Doping life in technical collaboration with Bureau Veritas Italia. This certification aims to enhance the value of companies engaged in promoting clean sport, with a set of actions that make it possible to guarantee products which are free of any potentially "doping" substances.

Roberto Lacorte, Vice Chairman of PharmaNutra Spa, stated: "Being able to count on a testimonial like Marcell Jacobs, whom I have the pleasure and the honour to welcome, means aiming for the very best, in no uncertain terms. And this is exactly what we have always done with our Cetilar® line, from all points of view. We are talking about the fastest man in the world, an athlete who, at the last Olympics, astonished and fuelled the dreams of enthusiasts all over the world, becoming a point of reference and an example for the younger generations. I am sure that this partnership will be an incentive for both of us as, although our commitment is to contribute to the improvement of his performance with our products, on the other hand Jacobs himself and his staff will have a vital role in providing us with direct feedback on their results, helping us to continue our ongoing work focused on the optimisation and improvement of the Cetilar® line".

Marcell Jacobs declared: "I am particularly delighted to embark on this important collaboration with Cetilar®, a prestigious brand that is already very active in the sports world, and whose products will accompany me throughout my journey and training preparations to ensure I reach the starting blocks at the next World and Olympic Championship events in perfect condition".

PharmaNutra S.p.A.

Founded and led by Chairman Andrea Lacorte and Vice Chairman Roberto Lacorte, PharmaNutra is a company established in 2003 that develops unique nutritional supplements and innovative medical devices, taking care of the entire production process, from proprietary raw materials to the finished product. PharmaNutra is a leader in the production of iron-based nutritional supplements under the SiderAL®brand, where it holds important patents on Sucrosomal®Technology, and is considered one of the emerging top players in the medical device sector dedicated to restoring joint capacity thanks to the Cetilar®brand. The effectiveness of the products is demonstrated by a number of scientific evidences, including more than 120 publications. In Italy, the sales activity is carried out through a network of over 160 Commercial Scientific Agents serving the medical class and dedicated to the exclusive marketing of products to pharmacies and parapharmacies throughout the national territory. Sales abroad are guaranteed in over 71 countries through 45 partners selected among the leading pharmaceutical companies. Over the years, the Group has developed a precise strategy in the management and production of intellectual property, based on the integrated management of all components: proprietary raw materials, patents, trademarks and clinical evidence.

PharmaNutra.it

For further details:
PharmaNutra S.p.A.	Press Office - Spriano Communication & Partners
Via Delle Lenze, 216/b - 56122 Pisa, Italy	Via Santa Radegonda, 16 - 20121 Milan, Italy
Tel. [phone]	Tel. [phone]
[e-mail]
Internal Press Office	Matteo Russo
[e-mail]

[e-mail]

Cristina Tronconi

[e-mail]